@violetyoung | NO | 43¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@quinngarza | YES | 47¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@frankiealvarez | NO | 42¢ | +37 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@emersonortega | NO | 51¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@loganzhao | YES | 55¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@wrenokafor | NO | 51¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@sagehale | YES | 56¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@haydennavarro | NO | 50¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@emersonortega | NO | 54¢ | +28 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@reesezhao | YES | 57¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@haydeningram | YES | 54¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@quinngarza | NO | 50¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@quinngarza | YES | 54¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@quinngarza | YES | 100¢ | +60 SP | Apple's biggest sleep feature launch in 2026: AirPods sleep tracking | |
@emersonortega | YES | 100¢ | +43 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@emersonortega | YES | 100¢ | +54 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@sagehale | YES | 100¢ | +42 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.0B – $3.5B | |
@frankieramos | YES | 100¢ | +60 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Under $3.0B | |
@blakepowell | YES | 100¢ | +60 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@ellachen | YES | 100¢ | +26 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@loganingram | YES | 100¢ | +30 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $4.0B – $4.5B | |
@emersonortega | YES | 53¢ | +27 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@wrenokafor | YES | 58¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@alexingram | YES | 68¢ | +32 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@frankieramos | YES | 66¢ | +42 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@kaipark | NO | 64¢ | +28 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@averykhan | YES | 67¢ | +42 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@alexingram | YES | 49¢ | +40 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@briarsantos | YES | 55¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@haydeningram | NO | 45¢ | +40 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@darbymoss | YES | 48¢ | +35 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@campbellsantos | YES | 50¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@haydeningram | YES | 64¢ | +41 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@frankieramos | YES | 46¢ | +41 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@averykhan | YES | 45¢ | +41 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@alexingram | YES | 61¢ | +41 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@daisykhan | YES | 42¢ | +37 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@briarsantos | YES | 51¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@micahpowell | NO | 37¢ | +41 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@graceyoung | YES | 47¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@frankieramos | NO | 37¢ | +41 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@campbellsantos | NO | 40¢ | +40 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@junejensen | NO | 43¢ | +40 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@alexingram | NO | 40¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@emersonortega | YES | 47¢ | +40 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@alexingram | YES | 58¢ | +25 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@haydeningram | NO | 41¢ | +40 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@ellachen | NO | 45¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@junejensen | NO | 49¢ | +40 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@marloweortega | YES | 55¢ | +40 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |